-The Times of India Days after a two-judge bench of the Supreme Court said it was time to revisit jurisprudence behind imposition of death penalty, the apex court asked the Union government why provisions in some laws mandating compulsory death penalty as punishment be not struck down as unconstitutional. The question from a bench of Justices Aftab Alam and Ranajana Desai put additional solicitor general Siddharth Luthra in a piquant position for...

-The Hindu India’s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price...

-The Economic Times The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well,...

-Outlook The Supreme Court today said it would examine the National Pharmaceutical Pricing Policy after it is notified with the Centre promising to do it within two weeks. A bench headed by Justice G S Singhvi granted two weeks time to the Centre to issue notification and posted the matter for hearing on December 12. Additional Solicitor General Siddharth Luthra informed the court that the Cabinet had approved the policy that will bring...

-The Telegraph The Union cabinet today approved a controversial drug pricing policy that had been opposed by the health ministry, the finance ministry and public health policy experts who fear it will legitimise high prices of medicines. A government source said the cabinet has cleared the drug pricing policy that health experts suspect will determine caps on prices of 348 drugs through a formula based on market prices of drugs rather than...